Skip to Content
Merck
  • Inhibitory effect of phthalic Acid on tyrosinase: the mixed-type inhibition and docking simulations.

Inhibitory effect of phthalic Acid on tyrosinase: the mixed-type inhibition and docking simulations.

Enzyme research (2011-06-04)
Shang-Jun Yin, Yue-Xiu Si, Guo-Ying Qian
ABSTRACT

Tyrosinase inhibition studies are needed due to the medicinal applications such as hyperpigmentation. For probing effective inhibitors of tyrosinase, a combination of computational prediction and enzymatic assay via kinetics was important. We predicted the 3D structure of tyrosinase, used a docking algorithm to simulate binding between tyrosinase and phthalic acid (PA), and studied the reversible inhibition of tyrosinase by PA. PA inhibited tyrosinase in a mixed-type manner with a K(i) = 65.84 ± 1.10 mM. Measurements of intrinsic and ANS-binding fluorescences showed that PA induced changes in the active site structure via indirect binding. Simulation was successful (binding energies for Dock6.3 = -27.22 and AutoDock4.2 = -0.97 kcal/mol), suggesting that PA interacts with LEU73 residue that is predicted commonly by both programs. The present study suggested that the strategy of predicting tyrosinase inhibition based on hydroxyl groups and orientation may prove useful for screening of potential tyrosinase inhibitors.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phthalic acid, ACS reagent, ≥99.5%
SKU
Pack Size
Availability
Price
Quantity